Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure

doi:10.3748/wjg.v21.i26.8203

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5490)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

348

WORD

165

HTML

2714

Figures (1-1)

146

Sum=3373

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1033

Download

1081

Sum=2114

Jul 14, 2015 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jul 14, 2015; 21(26): 8203-8207
Published online Jul 14, 2015. doi: 10.3748/wjg.v21.i26.8203

Open in New Tab Full Size Figure Download Figure

Figure 1 Clinical course of the patient, an 80-year-old Japanese female. White blood cells (WBC) and C-reactive protein (CRP) recovered within a few days after the initiation of recombinant thrombomodulin (rTM) treatment. PT (indicated by a bar) rose to 100.8% from 54.4%. WBC, CRP, and transaminase (GOT and GPT) all recovered, corresponding to the rTM administration. Tbil: Total bilirubin; TNF: Tumor necrosis factor; IL: Interleukin.

Citation: Kurokohchi K, Imataki O, Kubo F. Anti-inflammatory effect of recombinant thrombomodulin for fulminant hepatic failure. World J Gastroenterol 2015; 21(26): 8203-8207
URL: https://www.wjgnet.com/1007-9327/full/v21/i26/8203.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i26.8203